| |
Glecaprevir/Pibrentasvir is safe and effective in Italian
patients with chronic Hepatitis C aged 75 years or older:
a multicenter study (Global Hepatitis Summit 2023 April Paris)
|
| |
| |
presented at Global Hepatitis Summit 2023 April Paris
Nicola Pugliese, Vincenza Calvaruso, Mario Masarone, Roberta D’Ambrosio, Sara Battistella, Anna Licata, Marcello Persico, Maria Paola Anolli, Marco Distefano, Salvatore Petta, Francesco Paolo Russo, Vito Di Marco, Alessio Aghemo
| |
| |
| |
|
|
|
